Journal of Antimicrobial Chemotherapy · 2000 · 73 citations · 7 references
Veterinary MedicineInfectious DiseasesPharmacologyAntimicrobial PharmacotherapyAntimicrobial ResistanceMedical MicrobiologyAntibacterial PharmacologyAntibacterial PharmacotherapyAntibiotic ResistanceAntimicrobial Susceptibility TestingAntibiotic Resistance TestingFluoroquinolone AntibioticsHelicobacter Pylori InfectionHelicobacter Pylori TestingLinezolid Therapy
The in vitro activities of mupirocin, quinupristin/dalfopristin, linezolid, eperezolid, sitafloxacin, clinafloxacin, moxifloxacin, amoxycillin, metronidazole and clarithromycin were tested at pH 7.4 against 57 strains of Helicobacter pylori. The most active agents (mupirocin, sitafloxacin and clinafloxacin) were also tested for activity at pH 5.4 against the same strains. Mupirocin was very active at pH 7.4 and 5.4 (MIC90 0.25 and 0.12 mg/L, respectively). Quinupristin/dalfopristin, linezolid and eperezolid had low activity (MIC90 4, 8 and 4 mg/L, respectively). Sitafloxacin (MIC90 </= 0.008 mg/L) was the most active fluoroquinolone, while clinafloxacin (MIC90 0.12 mg/L) and moxifloxacin (MIC90 2 mg/L) were least active.
7
A. Bauernfeind · Journal of Antimicrobial Chemotherapy · 1997 · 302 citations · Full text
In vitro activity of HSR-903, a new quinolone
Yoshie Takahashi, Nobuhisa Masuda, Masako Otsuki et al. · Antimicrobial Agents and Chemotherapy · 1997 · 36 citations · Full text